GlaxoSmithKline AG - Omjjara 200 mg, Filmtabletten | | 69428 | | 03 | | Omjjara 200 mg | | Filmtabletten | | L01EJ04 | | | | 25.09.2024 | | |
| Composition | momelotinibum 200 mg ut momelotinibi dihydrochloridum monohydricum, cellulosum microcristallinum, lactosum monohydricum 101.52 mg, carboxymethylamylum natricum A, magnesii stearas, silica colloidalis anhydrica, E 310, Überzug: poly(alcohol vinylicus), macrogolum 3350, E 171, talcum, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium max. 1.51 mg. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose |
---|
Momelotinibum | 200 mg |
| BAG: Active Agent | Dose |
---|
Momelotinibum | 200 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | (Rubrum) | | | Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | E 310 | | | Lactose Monohydrate | 101.52 mg | | Macrogol | 3350 | | Magnesii Stearas | | | Poly(Alcohol Vinylicus) | | Überzug | Pro Compresso Obducto | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
003 | 30 | 4009.10 | 4376.55 | A | SL | No |
|
|